Randomised clinical trial: effects of monotherapy with ADX10059, a mGluR5 inhibitor, on symptoms and reflux events in patients with gastro-oesophageal reflux disease-Reference-Cited by-同舟云学术

Randomised clinical trial: effects of monotherapy with ADX10059, a mGluR5 inhibitor, on symptoms and reflux events in patients with gastro-oesophageal reflux disease

Published:2011-02-14 Issue:8 Volume:33 Page:911-921
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:

Author:

Zerbib F.,Bruley des Varannes S.,Roman S.,Tutuian R.,Galmiche J.-P.,Mion F.,Tack J.,Malfertheiner P.,Keywood C.

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2036.2011.04596.x/fullpdf

Reference25 articles.

1. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus;Vakil;Am J Gastroenterol,2006

2. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis;Chiba;Gastroenterology,1997

3. Management of heartburn not responding to proton pump inhibitors;Fass;Gut,2009

4. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring;Mainie;Gut,2006

5. Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy;Zerbib;Am J Gastroenterol,2006

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Experimental drugs for erosive esophagitis: what is in the clinical development pipeline?;Expert Opinion on Investigational Drugs;2024-08-30

2. A Comprehensive Review of Gastroesophageal Reflux Disease (GERD) Treatment and its Clinical Perspectives;International Journal of Pharmaceutical Sciences and Nanotechnology(IJPSN);2023-11-15

3. Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials;Signal Transduction and Targeted Therapy;2023-09-06

4. Clinical investigations of compounds targeting metabotropic glutamate receptors;Pharmacology Biochemistry and Behavior;2022-09

5. Targeting mGlu5 for Methamphetamine Use Disorder;Pharmacology & Therapeutics;2021-08